SYNTHESIS, ASSIGNMENT OF ABSOLUTE-CONFIGURATION, AND RECEPTOR-BINDING STUDIES RELEVANT TO THE NEUROLEPTIC ACTIVITIES OF A SERIES OF CHIRAL 3-SUBSTITUTED CYPROHEPTADINE ATROPISOMERS

被引:42
作者
RANDALL, WC
ANDERSON, PS
CRESSON, EL
HUNT, CA
LYON, TF
RITTLE, KE
REMY, DC
SPRINGER, JP
HIRSHFIELD, JM
HOOGSTEEN, K
WILLIAMS, M
RISLEY, EA
TOTARO, JA
机构
[1] MERCK SHARP & DOHME,RES LABS,RAHWAY,NJ 07065
[2] MERCK INST THERAPEUT RES,W POINT,PA 19486
关键词
D O I
10.1021/jm00196a014
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The syntheses and resolutions of chiral analogues of cyproheptadine bearing a cyano (1) and a trifluoromethylsulfonyl (8) suhstituent in the 3 position are described. The absolute configuration of (-)-3-bromocyproheptadine (5) was determined by X-ray crystal structure analysis to be pRapSb. The absolute configurations of 1, 8, and five other pairs of 3-substituted cyproheptadine analogues were related to the 3-bromo compound by circular dichroism spectrophotometry. The binding affinities of each member of the eight pairs of atropisomers as well as the parent unsubstituted cyproheptadine to membrane sites specifically binding tritiated ligands comprising the a-adrenergic agonist (-)-[3H] norepinephrine, the a-adrenergic antagonist [[[2-(2ʹ,6ʹ-[3H]dimethoxyphenoxy)ethyl]amino]-methyl]benzodioxane (WB-4101), the dopamine antagonist [3H]spiroperidol, and the muscarinic cholinergic antagonist [3H]quinuclidinyl benzilate (QNB) were measured by displacing these ligands from membrane preparations of mammalian brain. [34H]QNB was uniformly more easily displaced by the pSaRb absolute configuration of each pair, while the remaining three ligands were more easily displaced by isomers of the pSaRb configuration. Quantitative structure-activity relationships demonstrate only modest correlations between the receptor binding data and physical parameters of the 3-substituents, indicating the complex nature of the drug-receptor interactions. © 1979, American Chemical Society. All rights reserved.
引用
收藏
页码:1222 / 1230
页数:9
相关论文
共 37 条
  • [1] BARR AJ, 1976, USERS GUIDE SAS76
  • [2] BURT DR, 1976, MOL PHARMACOL, V12, P800
  • [3] SPECIFICATION OF MOLECULAR CHIRALITY
    CAHN, RS
    INGOLD, C
    PRELOG, V
    [J]. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 1966, 5 (04) : 385 - &
  • [4] 2-POINT CALIBRATION OF CIRCULAR DICHROMETER WITH D-10-CAMPHORSULFONIC ACID
    CHEN, GC
    YANG, JT
    [J]. ANALYTICAL LETTERS, 1977, 10 (14) : 1195 - 1207
  • [5] CLINESCHMIDT BV, 1979, PHARM EXP THER, V208, P460
  • [6] CREESE I, 1978, NEUROTRANSMITTER REC, P141
  • [7] DRAPER N, 1966, APPLIED REGRESSION A
  • [8] STRUCTURE-ACTIVITY RELATIONSHIPS IN CYPROHEPTADINE SERIES
    ENGELHARDT, EL
    ZELL, HC
    SAARI, WS
    CHRISTY, ME
    COLTON, CD
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1965, 8 (06) : 829 - +
  • [9] STEREOSPECIFICITY OF INTERACTION OF NEUROLEPTIC DRUGS WITH NEUROTRANSMITTERS AND CORRELATION WITH CLINICAL POTENCY
    ENNA, SJ
    BENNETT, JP
    BURT, DR
    CREESE, I
    SNYDER, SH
    [J]. NATURE, 1976, 263 (5575) : 338 - 341
  • [10] STEREOSPECIFICITY AND CLINICAL POTENCY OF NEUROLEPTICS - REPLY
    ENNA, SJ
    BENNETT, JP
    BURT, DR
    CREESE, I
    UPRICHARD, DC
    GREENBERG, DA
    SNYDER, SH
    [J]. NATURE, 1977, 267 (5607) : 184 - 184